Generate a tailored SOP for Dr. Lynn Quek. Improve your application with a focused, well-structured draft.
Lynn Quek is a Clinical Senior Lecturer and Chief Investigator at King's College London, specializing in Myelodysplasia (MDS) and Acute Myeloid Leukemia (AML). With a background as an MRC Clinician Scientist and Consultant Haematologist, Dr. Quek's research focuses on understanding clonal hematopoietic cell populations and their role in blood diseases, particularly the evolution of myeloid disorders and the biology of leukemia stem cells. She employs integrated genomic and functional approaches coupled with single-cell techniques to dissect clonal structures and epigenetic/transcriptional heterogeneity relevant to MDS and AML. Among her ongoing projects, Dr. Quek investigates mechanisms of clonal hematopoiesis and epigenetic factors influencing differentiation arrest in leukemia. Her work aims to translate scientific insights into actionable clinical care for patients with hematological malignancies.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.